Agios Pharmaceuticals
AGIO
#5052
Rank
A$2.43 B
Marketcap
A$41.75
Share price
1.13%
Change (1 day)
-56.65%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2025 (TTM): -A$0.75 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are A$44.79 Million. In 2024 the company made an earning of -A$0.65 Billion a decrease over its 2023 earnings that were of -A$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.75 Billion15.73%
2024 -A$0.65 Billion8.75%
2023 -A$0.59 Billion0.63%
2022 -A$0.59 Billion2.81%
2021 -A$0.57 Billion10.58%
2020 -A$0.52 Billion-18.41%
2019 -A$0.64 Billion15.72%
2018 -A$0.55 Billion12.99%
2017 -A$0.49 Billion59.61%
2016 -A$0.31 Billion69.32%
2015 -A$0.18 Billion119.28%
2014 -A$81.5 Million39.22%
2013 -A$58.54 Million69.1%
2012 -A$34.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Xencor
XNCR
-A$0.21 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.31 B-283.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.84 B-2,592.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.02 B-242.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$14.03 B-2,060.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
A$33.87 B-4,831.71%๐Ÿ‡บ๐Ÿ‡ธ USA